NCT03430011 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- JCARH125 IV at dose level 50 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG000
- title
- Phase 1 50 x 10^6 Cells
- description
- JCARH125 IV at dose level 150 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG001
- title
- Phase 1 150 x 10^6 Cells
- description
- JCARH125 IV at dose level 300 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG002
- title
- Phase 1 300 x 10^6 Cells
- description
- JCARH125 IV at dose level 450 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG003
- title
- Phase 1 450 x 10^6 Cells
- description
- JCARH125 IV at dose level 600 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG004
- title
- Phase 1 600 x 10^6 Cells
- description
- 2 doses of 100 mg anakinra administered subcutaneously (SC) for 5 consecutive days + JCARH125 IV at dose level 600 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG005
- title
- Phase 1 Anakinra 600 x 10^6 Cells
- description
- JCARH125 IV at dose level 600 x 10\^6 consisting of CD3+CAR+T cells expansion
- id
- FG006
- title
- Phase 2 600 x 10^6 Cells
- description
- JCARH125 IV at dose level 600 x 10\^6 consisting of CD3+CAR+T cells in participants previously treated with BCMA-directed anti-myeloma therapy
- id
- FG007
- title
- Phase 2a 600 x 10^6 Cells Anti-BCMA
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 0
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Screen Fail
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- No JCARH125 - disease related complications
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Participant not eligible - other reasons
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 15
- group Id
- FG001
- num Subjects
- 30
- group Id
- FG002
- num Subjects
- 27
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 22
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 25
- group Id
- FG007
- num Subjects
- 10
- comment
- Underwent Leukapheresis
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 15
- group Id
- FG001
- num Subjects
- 30
- group Id
- FG002
- num Subjects
- 26
- group Id
- FG003
- num Subjects
- 21
- group Id
- FG004
- num Subjects
- 20
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 24
- group Id
- FG007
- num Subjects
- 10
- type
- Received Lymphodepleting Chemotherapy (LDC)
- achievements
- group Id
- FG000
- num Subjects
- 14
- group Id
- FG001
- num Subjects
- 30
- group Id
- FG002
- num Subjects
- 26
- group Id
- FG003
- num Subjects
- 21
- group Id
- FG004
- num Subjects
- 20
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 24
- group Id
- FG007
- num Subjects
- 10
- comment
- Received JCARH125
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 2
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Pre-Treatment
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 5
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 4
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 3
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 0
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 10
- group Id
- FG003
- num Subjects
- 8
- group Id
- FG004
- num Subjects
- 5
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 2
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 4
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 2
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 3
- group Id
- FG007
- num Subjects
- 2
- type
- Other reasons
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 14
- group Id
- FG001
- num Subjects
- 30
- group Id
- FG002
- num Subjects
- 26
- group Id
- FG003
- num Subjects
- 21
- group Id
- FG004
- num Subjects
- 20
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 24
- group Id
- FG007
- num Subjects
- 10
- comment
- Received JCARH125
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 8
- group Id
- FG001
- num Subjects
- 9
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 6
- group Id
- FG004
- num Subjects
- 9
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 11
- group Id
- FG007
- num Subjects
- 3
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 21
- group Id
- FG002
- num Subjects
- 19
- group Id
- FG003
- num Subjects
- 15
- group Id
- FG004
- num Subjects
- 11
- group Id
- FG005
- num Subjects
- 8
- group Id
- FG006
- num Subjects
- 13
- group Id
- FG007
- num Subjects
- 7
- type
- NOT COMPLETED
- title
- JCARH125 Treatment
Complete source fields
- groups
- description
- JCARH125 IV at dose level 50 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG000
- title
- Phase 1 50 x 10^6 Cells
- description
- JCARH125 IV at dose level 150 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG001
- title
- Phase 1 150 x 10^6 Cells
- description
- JCARH125 IV at dose level 300 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG002
- title
- Phase 1 300 x 10^6 Cells
- description
- JCARH125 IV at dose level 450 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG003
- title
- Phase 1 450 x 10^6 Cells
- description
- JCARH125 IV at dose level 600 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG004
- title
- Phase 1 600 x 10^6 Cells
- description
- 2 doses of 100 mg anakinra administered subcutaneously (SC) for 5 consecutive days + JCARH125 IV at dose level 600 x 10\^6 consisting of CD3+CAR+T cells
- id
- FG005
- title
- Phase 1 Anakinra 600 x 10^6 Cells
- description
- JCARH125 IV at dose level 600 x 10\^6 consisting of CD3+CAR+T cells expansion
- id
- FG006
- title
- Phase 2 600 x 10^6 Cells
- description
- JCARH125 IV at dose level 600 x 10\^6 consisting of CD3+CAR+T cells in participants previously treated with BCMA-directed anti-myeloma therapy
- id
- FG007
- title
- Phase 2a 600 x 10^6 Cells Anti-BCMA
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 0
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Screen Fail
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- No JCARH125 - disease related complications
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Participant not eligible - other reasons
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 15
- group Id
- FG001
- num Subjects
- 30
- group Id
- FG002
- num Subjects
- 27
- group Id
- FG003
- num Subjects
- 22
- group Id
- FG004
- num Subjects
- 22
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 25
- group Id
- FG007
- num Subjects
- 10
- comment
- Underwent Leukapheresis
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 15
- group Id
- FG001
- num Subjects
- 30
- group Id
- FG002
- num Subjects
- 26
- group Id
- FG003
- num Subjects
- 21
- group Id
- FG004
- num Subjects
- 20
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 24
- group Id
- FG007
- num Subjects
- 10
- type
- Received Lymphodepleting Chemotherapy (LDC)
- achievements
- group Id
- FG000
- num Subjects
- 14
- group Id
- FG001
- num Subjects
- 30
- group Id
- FG002
- num Subjects
- 26
- group Id
- FG003
- num Subjects
- 21
- group Id
- FG004
- num Subjects
- 20
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 24
- group Id
- FG007
- num Subjects
- 10
- comment
- Received JCARH125
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 1
- group Id
- FG004
- num Subjects
- 2
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 0
- type
- NOT COMPLETED
- title
- Pre-Treatment
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 5
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 4
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 3
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 1
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 0
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 10
- group Id
- FG003
- num Subjects
- 8
- group Id
- FG004
- num Subjects
- 5
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 2
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 4
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 2
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 3
- group Id
- FG007
- num Subjects
- 2
- type
- Other reasons
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 14
- group Id
- FG001
- num Subjects
- 30
- group Id
- FG002
- num Subjects
- 26
- group Id
- FG003
- num Subjects
- 21
- group Id
- FG004
- num Subjects
- 20
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 24
- group Id
- FG007
- num Subjects
- 10
- comment
- Received JCARH125
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 8
- group Id
- FG001
- num Subjects
- 9
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 6
- group Id
- FG004
- num Subjects
- 9
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 11
- group Id
- FG007
- num Subjects
- 3
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 6
- group Id
- FG001
- num Subjects
- 21
- group Id
- FG002
- num Subjects
- 19
- group Id
- FG003
- num Subjects
- 15
- group Id
- FG004
- num Subjects
- 11
- group Id
- FG005
- num Subjects
- 8
- group Id
- FG006
- num Subjects
- 13
- group Id
- FG007
- num Subjects
- 7
- type
- NOT COMPLETED
- title
- JCARH125 Treatment
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle